Dear Reader,
I hope this email finds you well. I'm thrilled to share an exciting update regarding SILO Pharma Inc. (NASDAQ: SILO). As an early bird alert, I wanted to inform you that gains are holding strong with SILO, and now is an opportune moment to continue your research on this exciting company.
In recent filings, it has come to light that Silo Pharma Inc. (NASDAQ: SILO) has
initiated a significant buyback program, repurchasing 600,000 shares of its own stock. This strategic move not only demonstrates the company's confidence in its future prospects but also serves as a testament to its commitment to enhancing shareholder value.
Furthermore, insider activity within the company has caught our attention. Insiders, who are privy to the inner workings and potential of Silo Pharma Inc., have been actively purchasing shares. This insider buying serves
as a bullish signal, indicating that those closest to the company believe in its growth trajectory and are putting their own capital behind it.
As always, conducting thorough research and due diligence is essential when researching companies. With Silo Pharma Inc. showing resilience in its gains, coupled with recent positive developments, now may be an ideal time to delve deeper into what this company has to offer.
Stay informed, stay vigilant, and keep an
eye on Silo Pharma Inc. (NASDAQ: SILO) as it continues to navigate the ever-evolving landscape of pharmaceuticals.
Best regards,
Max Masters
Co-founder, Market Tips Newsletter
